Met Life Investment Management, LLC Teva Pharmaceutical Industries LTD Transaction History

Met Life Investment Management, LLC

  • $18.1 Billion
  • Q1 2025

A detailed history of Met Life Investment Management, LLC transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Met Life Investment Management, LLC holds 120,825 shares of TEVA stock, worth $2.05 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
120,825
Previous 133,425 9.44%
Holding current value
$2.05 Million
Previous $2.94 Million 36.84%
% of portfolio
0.01%
Previous 0.02%

Shares

49 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025
SELL
$14.67 - $22.01 $184,842 - $277,326
-12,600 Reduced 9.44%
120,825 $1.86 Million
Q4 2024

Feb 13, 2025
BUY
$16.43 - $22.77 $630,912 - $874,368
38,400 Added 40.41%
133,425 $2.94 Million
Q3 2024

Nov 13, 2024
SELL
$15.81 - $18.96 $159,681 - $191,496
-10,100 Reduced 9.61%
95,025 $1.71 Million
Q2 2024

Aug 13, 2024
BUY
$12.78 - $17.4 $535,124 - $728,572
41,872 Added 66.2%
105,125 $1.71 Million
Q1 2024

May 14, 2024
BUY
$10.67 - $14.43 $674,909 - $912,740
63,253 New
63,253 $892,000
Q2 2023

Apr 29, 2024
BUY
$7.2 - $9.47 $455,421 - $599,005
63,253 New
63,253 $476,000
Q1 2023

May 09, 2024
BUY
$8.36 - $11.37 $528,795 - $719,186
63,253 New
63,253 $560 Million
Q1 2023

May 15, 2023
SELL
$8.36 - $11.37 $104,500 - $142,125
-12,500 Reduced 16.5%
63,253 $559,000
Q4 2022

Jun 14, 2023
BUY
$7.95 - $9.48 $99,375 - $118,500
12,500 Added 19.76%
75,753 $690,000
Q4 2022

Feb 15, 2023
SELL
$7.95 - $9.48 $34,980 - $41,712
-4,400 Reduced 4.59%
91,553 $834,000
Q3 2022

Jun 14, 2023
BUY
$6.86 - $11.95 $85,750 - $149,375
12,500 Added 19.76%
75,753 $611,000
Q2 2022

Jun 20, 2023
BUY
$7.38 - $10.4 $92,250 - $130,000
12,500 Added 19.76%
75,753 $569,000
Q1 2022

May 10, 2024
BUY
$7.33 - $9.39 $555,269 - $711,320
75,753 New
75,753 $711,000
Q1 2022

Jun 20, 2023
BUY
$7.33 - $9.39 $91,625 - $117,375
12,500 Added 19.76%
75,753 $711,000
Q1 2022

May 12, 2022
BUY
$7.33 - $9.39 $31,519 - $40,377
4,300 Added 4.69%
95,953 $901,000
Q4 2021

Jun 21, 2023
BUY
$7.9 - $10.19 $98,750 - $127,375
12,500 Added 19.76%
75,753 $606,000
Q3 2021

Jun 21, 2023
BUY
$8.38 - $10.18 $104,750 - $127,250
12,500 Added 19.76%
75,753 $737,000
Q3 2021

Mar 22, 2023
SELL
$8.38 - $10.18 $133,242 - $161,862
-15,900 Reduced 17.35%
75,753 $737,000
Q2 2021

Jun 21, 2023
BUY
$9.9 - $11.56 $123,750 - $144,500
12,500 Added 19.76%
75,753 $749,000
Q2 2021

Mar 22, 2023
BUY
$9.9 - $11.56 $157,410 - $183,804
15,900 Added 20.99%
91,653 $907,000
Q2 2021

Aug 16, 2021
SELL
$9.9 - $11.56 $38,610 - $45,084
-3,900 Reduced 4.08%
91,653 $907,000
Q1 2021

May 17, 2024
BUY
$10.34 - $12.81 $129,250 - $160,125
12,500 Added 19.76%
75,753 $874,000
Q1 2021

Jun 26, 2023
BUY
$10.34 - $12.81 $129,250 - $160,125
12,500 Added 19.76%
75,753 $874 Million
Q1 2021

Mar 22, 2023
SELL
$10.34 - $12.81 $138,556 - $171,654
-13,400 Reduced 15.03%
75,753 $874,000
Q1 2021

May 14, 2021
SELL
$10.34 - $12.81 $138,556 - $171,654
-13,400 Reduced 12.3%
95,553 $1.1 Million
Q4 2020

Jun 22, 2023
BUY
$8.61 - $11.04 $222,998 - $285,936
25,900 Added 40.95%
89,153 $860,000
Q4 2020

Feb 16, 2021
SELL
$8.61 - $11.04 $37,884 - $48,575
-4,400 Reduced 3.88%
108,953 $1.05 Million
Q3 2020

May 24, 2024
BUY
$8.57 - $12.69 $95,984 - $142,128
11,200 Added 14.37%
89,153 $803 Million
Q3 2020

Jun 26, 2023
BUY
$8.57 - $12.69 $221,963 - $328,671
25,900 Added 40.95%
89,153 $803,000
Q3 2020

Mar 22, 2023
BUY
$8.57 - $12.69 $95,984 - $142,128
11,200 Added 14.37%
89,153 $803,000
Q3 2020

Nov 13, 2020
BUY
$8.57 - $12.69 $66,846 - $98,982
7,800 Added 7.39%
113,353 $1.02 Million
Q2 2020

May 24, 2024
BUY
$8.12 - $13.12 $119,363 - $192,864
14,700 Added 23.24%
77,953 $961 Million
Q2 2020

Jun 26, 2023
BUY
$8.12 - $13.12 $119,363 - $192,864
14,700 Added 23.24%
77,953 $961,000
Q2 2020

Aug 14, 2020
BUY
$8.12 - $13.12 $60,899 - $98,400
7,500 Added 7.65%
105,553 $1.3 Million
Q1 2020

Jul 12, 2023
BUY
$6.69 - $13.45 $98,343 - $197,715
14,700 Added 23.24%
77,953 $700,000
Q4 2019

Jul 12, 2023
BUY
$6.53 - $10.72 $95,991 - $157,584
14,700 Added 23.24%
77,953 $763,000
Q3 2019

Jul 12, 2023
BUY
$6.16 - $9.6 $90,552 - $141,120
14,700 Added 23.24%
77,953 $536,000
Q3 2019

Nov 14, 2019
BUY
$6.16 - $9.6 $25,256 - $39,360
4,100 Added 4.36%
98,053 $675,000
Q2 2019

Jul 12, 2023
BUY
$8.12 - $15.72 $119,363 - $231,084
14,700 Added 23.24%
77,953 $719,000
Q2 2019

Mar 22, 2023
BUY
$8.12 - $15.72 $61,711 - $119,472
7,600 Added 10.8%
77,953 $719,000
Q2 2019

Aug 14, 2019
BUY
$8.12 - $15.72 $77,139 - $149,340
9,500 Added 11.25%
93,953 $867,000
Q1 2019

Jul 13, 2023
BUY
$15.58 - $20.01 $110,618 - $142,071
7,100 Added 11.22%
70,353 $1.1 Million
Q1 2019

May 15, 2019
BUY
$15.58 - $20.01 $219,678 - $282,141
14,100 Added 20.04%
84,453 $1.32 Million
Q4 2018

Jul 13, 2023
BUY
$14.59 - $23.84 $103,589 - $169,264
7,100 Added 11.22%
70,353 $1.08 Million
Q3 2018

Jul 13, 2023
BUY
$21.06 - $25.65 $149,526 - $182,115
7,100 Added 11.22%
70,353 $1.52 Million
Q3 2018

Mar 22, 2023
SELL
$21.06 - $25.65 $446,472 - $543,780
-21,200 Reduced 23.16%
70,353 $1.52 Million
Q2 2018

Aug 15, 2018
BUY
$16.77 - $24.71 $127,452 - $187,796
7,600 Added 12.11%
70,353 $1.71 Million
Q1 2018

May 15, 2018
SELL
$16.68 - $22.07 $128,436 - $169,939
-7,700 Reduced 10.93%
62,753 $1.07 Million
Q4 2017

Feb 15, 2018
BUY
$11.23 - $19.1 $791,187 - $1.35 Million
70,453
70,453 $1.34 Million

Others Institutions Holding TEVA

# of Institutions
660
Shares Held
627M
Call Options Held
27.9M
Put Options Held
21.8M
View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

TEVA Quotes by TradingView
  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $18.8B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email